Spectrum Science’s TrialBlazer
More Seamless Clinical Trial Prescreening
In the U.S., 80% of Americans are aware of the existence of clinical trials, and close to three in four (72%) are open to joining a clinical trial, yet only a small percentage of patients actually do each year. And even though patients typically seek clinical trial information outside of their physician by going through social media or digital platforms, approximately 90% of individuals who start a prescreener do not enroll in a clinical trial.
As a full-service patient recruitment partner, Spectrum Science is passionate about optimizing the clinical trial experience for every stakeholder. That’s why they’ve developed TrialBlazer, a proprietary pre-screening software solution that aids in the acceleration of clinical trial enrollment by helping individuals find clinical trials. This digital prescreener technology can seamlessly integrate into websites, third-party media partners, and other digital platforms.
TrialBlazer includes three key distinguishing features. First, is an interactive prescreener that creates a more seamless and improved user experience for potential trial participants through an integrated prescreening and patient CRM communication platform. Second, TrialBlazer’s Intelligence engine enables programmatic patient matching for individual studies, population disease states, or across a sponsor’s therapeutic franchises, enhancing the likelihood of patients finding suitable trial matches now or in the future. This also decreases site burden by connecting prequalified patients to research sites in one standardized referral process. Third, is a data lake that compiles and displays enterprise-level metrics in a singular platform view allowing for faster optimization decisions and more efficient reporting.
The first iteration of TrialBlazer launched in Q1 2023 and has been successfully running its first campaign.
